NASDAQ:PHAT | Free Cash Flow | Phathom Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$15.65M$61,000.00-$15.71M
2025-12-31-$5M$87,000.00-$5.09M
2025-03-31-$84.93M$18,000.00-$84.95M
2024-12-31-$63.46M$5,000.00-$63.46M
2024-03-31-$69.02M$40,000.00-$69.06M
2023-12-31-$43.8M$475,000.00-$44.27M
2023-03-31-$39.67M$214,000.00-$39.88M
2022-12-31-$41.04M$412,000.00-$41.45M
2022-03-31-$44.76M$67,000.00-$44.82M
2021-12-31-$41.26M$100,000.00-$41.36M
2021-03-31-$49.77M$169,000.00-$49.93M
2020-12-31-$28.2M$124,000.00-$28.32M
2020-03-31-$11.42M$676,000.00-$12.09M
2019-12-31-$23.38M$106,000.00-$23.49M
2019-03-31-$807,000.00
2018-12-31-$302,000.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$166.78M$229,000.00-$167M
2024-12-31-$266.77M$135,000.00-$266.91M
2023-12-31-$137.58M$1.63M-$139.21M
2022-12-31-$146.53M$1.04M-$147.57M
2021-12-31-$148.46M$328,000.00-$148.79M
2020-12-31-$69.69M$1.04M-$70.73M
2019-12-31-$36.51M$132,000.00-$36.64M
2018-12-31-$1.02M